Please wait

Exhibit 107.1

Calculation of Filing Fee Table

Registration Statement on Form S-3

(Form Type)

Aligos Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                 
     Security
Type		   Security
Class
Title		   Fee
Calculation
or Carry
Forward
Rule		   Amount
Registered		   Proposed
Maximum
Offering
Price Per
Unit(2)		   Maximum
Aggregate
Offering
Price(2)		   Fee
Rate		   Amount of
Registration
Fee
                 
Fees to Be Paid   Equity   Common Stock, par value $0.0001 per share   457(c)   6,245,475(1)    $11.05   $69,012,498.75   0.0001476   $10,565.82
           
    Total Offering Amounts     $69,012,498.75     $10,565.82
           
    Total Fees Previously Paid         —
           
    Total Fee Offsets(3)         —
           
    Net Fee Due               $10,565.82

 

(1)

Consists of (i) 1,510,055 shares of the registrant’s common stock issued to the selling stockholders, (ii) 800,000 shares of the registrant’s common stock issuable to certain of the selling stockholders upon conversion of outstanding shares of the registrant’s non-voting common stock, (iii) 1,922,511 shares of the registrant’s common stock issuable to certain of the selling stockholders upon exercise of outstanding pre-funded warrants to purchase common stock and (iv) 2,012,909 shares of the registrant’s common stock issuable to the selling stockholders upon exercise of outstanding common warrants. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares of common stock being registered hereunder as a result of any stock dividend, stock split, recapitalization or similar transaction.

(2)

Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, on the basis of the average of the high and low prices for a share of the registrant’s common stock as reported on the Nasdaq Global Select Market on March 24, 2025, which date is within five business days prior to the filing of this Registration Statement.

(3)

The registrant does not have any fee offsets.